• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症监护病房碳青霉烯类耐药感染的发生率及危险因素:一项匹配病例对照研究。

Incidence and risk factors of carbapenem-resistant infection in intensive care units: a matched case-control study.

机构信息

College of Medicine, King Saud Bin Abdulaziz University for Health Science, Riyadh, Saudi Arabia.

Clinical Pharmacy, King Abdulaziz Medical City, Riyadh, Saudi Arabia.

出版信息

Expert Rev Anti Infect Ther. 2021 Mar;19(3):393-398. doi: 10.1080/14787210.2020.1822736. Epub 2020 Sep 20.

DOI:10.1080/14787210.2020.1822736
PMID:32930620
Abstract

BACKGROUND

Carbapenem-resistant (CRE) infection is associated with intensive care admissions, morbidity, and mortality. Our study aimed to determine the incidence, risk factors, and patient outcomes of CRE in the ICU units.

METHODS

This was a retrospective matched case-control study of patients admitted to ICUs. Patients who have positive cultures of CRE and carbapenem-susceptible (CSE) were included in the study. Patients were randomly selected from a pool of CSE subjects in a ratio of 1:1 of CRE to CSE as control patients.

RESULTS

The infection rate with CRE among all patients admitted to ICUs was 7.6% and the incidence of CRE infection was 5.6 per 1,000 person-day. The risk factors independently associated with CRE infection were: Higher Sequential Organ Failure Assessment (SOFA) and Nutrition Risk in Critically ill (NUTRIC) scores, prolonged ICU length of stay (LOS), previous surgery, dialysis and mechanical ventilation during ICU stay, and previous use of aminoglycoside and carbapenems.

CONCLUSION

In this retrospective study, the incidence of CRE infection was relatively elevated in patients admitted to ICU. Patients with high SOFA and NUTRIC scores, prolonged ICU LOS, previous surgery, dialysis and mechanical ventilation, and prior aminoglycosides and carbapenems use, may have an increased risk of CRE infection.

摘要

背景

耐碳青霉烯肠杆菌科(CRE)感染与重症监护病房(ICU)入住、发病率和死亡率有关。我们的研究旨在确定 ICU 中 CRE 的发病率、危险因素和患者结局。

方法

这是一项 ICU 住院患者的回顾性匹配病例对照研究。CRE 阳性培养和碳青霉烯敏感(CSE)的患者纳入研究。从 CSE 患者中随机抽取患者,与 CRE 患者以 1:1 的比例作为对照患者。

结果

所有 ICU 住院患者中 CRE 的感染率为 7.6%,CRE 感染的发病率为每 1000 人日 5.6 例。与 CRE 感染独立相关的危险因素是:更高的序贯器官衰竭评估(SOFA)和危重症营养风险(NUTRIC)评分、ICU 住院时间延长、既往手术、透析和机械通气,以及 ICU 期间使用氨基糖苷类和碳青霉烯类药物。

结论

在这项回顾性研究中,ICU 住院患者的 CRE 感染发生率相对较高。SOFA 和 NUTRIC 评分较高、ICU 住院时间延长、既往手术、透析和机械通气以及先前使用氨基糖苷类和碳青霉烯类药物的患者,可能有更高的 CRE 感染风险。

相似文献

1
Incidence and risk factors of carbapenem-resistant infection in intensive care units: a matched case-control study.重症监护病房碳青霉烯类耐药感染的发生率及危险因素:一项匹配病例对照研究。
Expert Rev Anti Infect Ther. 2021 Mar;19(3):393-398. doi: 10.1080/14787210.2020.1822736. Epub 2020 Sep 20.
2
Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.重症患者中耐碳青霉烯类肠杆菌科细菌的定植与感染:与非携带者的回顾性匹配队列比较
J Hosp Infect. 2016 Sep;94(1):54-9. doi: 10.1016/j.jhin.2016.05.018. Epub 2016 Jun 6.
3
Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: A case-control study.多黏菌素 B 和碳青霉烯类耐药肠杆菌科分离株相关的危险因素和结局:一项病例对照研究。
Int J Antimicrob Agents. 2019 May;53(5):657-662. doi: 10.1016/j.ijantimicag.2019.03.011. Epub 2019 Mar 14.
4
Epidemiology of Carbapenem-resistant Enterobacteriaceae in Egyptian intensive care units using National Healthcare-associated Infections Surveillance Data, 2011-2017.2011-2017 年利用国家医疗保健相关感染监测数据对埃及重症监护病房耐碳青霉烯肠杆菌科的流行病学研究。
Antimicrob Resist Infect Control. 2020 Jan 3;9(1):2. doi: 10.1186/s13756-019-0639-7. eCollection 2020.
5
The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan.耐碳青霉烯类肠杆菌科细菌定植与感染的流行病学及危险因素:日本一家机构的病例对照研究
J Infect Chemother. 2018 Jul;24(7):505-509. doi: 10.1016/j.jiac.2018.02.005. Epub 2018 Mar 13.
6
Increased Risk for Carbapenem-Resistant Enterobacteriaceae Colonization in Intensive Care Units after Hospitalization in Emergency Department.在急诊住院后,重症监护病房中耐碳青霉烯类肠杆菌科定植的风险增加。
Emerg Infect Dis. 2020 Jun;26(6):1156-1163. doi: 10.3201/eid2606.190965. Epub 2020 Jun 17.
7
Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.儿童耐碳青霉烯肠杆菌科定植或感染的危险因素的多中心研究。
Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.01440-17. Print 2017 Dec.
8
Prevalence and Risk Factors of Carbapenem-resistant Acquisition in an Emergency Intensive Care Unit in a Tertiary Hospital in Korea: a Case-Control Study.韩国一家三级医院急诊重症监护病房耐碳青霉烯类获得性的流行状况和危险因素:一项病例对照研究。
J Korean Med Sci. 2019 May 13;34(18):e140. doi: 10.3346/jkms.2019.34.e140.
9
[Clinical characteristics of carbapenem-resistant infection in pediatric liver transplantation recipients].[儿童肝移植受者碳青霉烯类耐药感染的临床特征]
Zhonghua Er Ke Za Zhi. 2020 Aug 2;58(8):640-645. doi: 10.3760/cma.j.cn112140-20200316-00239.
10
Incidence of a subsequent carbapenem-resistant Enterobacteriaceae infection after previous colonisation or infection: a prospective cohort study.定植或感染碳青霉烯类耐药肠杆菌科细菌后后续感染的发生率:一项前瞻性队列研究。
Int J Antimicrob Agents. 2021 Jun;57(6):106340. doi: 10.1016/j.ijantimicag.2021.106340. Epub 2021 Apr 20.

引用本文的文献

1
Prevalence and mortality associated with multidrug-resistant infections in adult intensive care units in Argentina (PREV-AR).阿根廷成人重症监护病房多重耐药感染的患病率及死亡率(PREV-AR)。
Antimicrob Agents Chemother. 2025 Mar 5;69(3):e0142624. doi: 10.1128/aac.01426-24. Epub 2025 Jan 22.
2
Risk Factors Analysis and Prediction Model Establishment for Carbapenem-Resistant Enterobacteriaceae Colonization: A Retrospective Cohort Study.耐碳青霉烯类肠杆菌科细菌定植的危险因素分析及预测模型建立:一项回顾性队列研究
Infect Drug Resist. 2024 Oct 28;17:4717-4726. doi: 10.2147/IDR.S485915. eCollection 2024.
3
Incidence of and Risk Factors for Third-Generation Cephalosporin-Resistant Bloodstream Infections in Children.
儿童耐第三代头孢菌素血流感染的发病率及危险因素
Infect Drug Resist. 2024 Feb 9;17:543-550. doi: 10.2147/IDR.S449731. eCollection 2024.
4
Molecular characterization of carbapenem-resistance in Gram-negative isolates obtained from clinical samples at Jimma Medical Center, Ethiopia.埃塞俄比亚吉马医疗中心从临床样本中分离出的革兰氏阴性菌对碳青霉烯类抗生素耐药性的分子特征分析
Front Microbiol. 2024 Jan 24;15:1336387. doi: 10.3389/fmicb.2024.1336387. eCollection 2024.
5
An analysis of differences in Carbapenem-resistant Enterobacterales in different regions: a multicenter cross-sectional study.不同地区碳青霉烯类耐药肠杆菌科细菌的差异分析:一项多中心横断面研究。
BMC Infect Dis. 2024 Jan 22;24(1):116. doi: 10.1186/s12879-024-09005-9.
6
Role of Probiotics in Preventing Carbapenem-Resistant Colonization in the Intensive Care Unit: Risk Factors and Microbiome Analysis Study.益生菌在预防重症监护病房耐碳青霉烯类细菌定植中的作用:危险因素与微生物组分析研究
Microorganisms. 2023 Dec 12;11(12):2970. doi: 10.3390/microorganisms11122970.
7
Comparison of bloodstream and non-bloodstream infections caused by carbapenem-resistant in the intensive care unit: a 9-year respective study.重症监护病房中耐碳青霉烯类细菌引起的血流感染与非血流感染的比较:一项为期9年的回顾性研究。
Front Med (Lausanne). 2023 Sep 14;10:1230721. doi: 10.3389/fmed.2023.1230721. eCollection 2023.
8
Carbapenems β-lactam and β-lactamase inhibitors for treatment of nosocomial pneumonia: A systematic review and meta-analysis.碳青霉烯类β-内酰胺类及β-内酰胺酶抑制剂用于治疗医院获得性肺炎:一项系统评价与荟萃分析。
Heliyon. 2023 Sep 13;9(10):e20108. doi: 10.1016/j.heliyon.2023.e20108. eCollection 2023 Oct.
9
Prevalence of Multidrug-Resistant Pathogens Causing Neonatal Early and Late Onset Sepsis, a Retrospective Study from the Tertiary Referral Children's Hospital.引起新生儿早发型和晚发型败血症的多重耐药病原体的患病率:来自三级转诊儿童医院的一项回顾性研究
Infect Drug Resist. 2023 Jun 29;16:4213-4225. doi: 10.2147/IDR.S416020. eCollection 2023.
10
Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales.头孢地尔,一种铁载体头孢菌素,作为耐碳青霉烯类肠杆菌科细菌所致感染的一种治疗选择。
Infect Dis Ther. 2023 Mar;12(3):777-806. doi: 10.1007/s40121-023-00773-6. Epub 2023 Feb 25.